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Abstract
DNA methylation is one of the key epigenetic mechanisms essential for 
transcriptional regulation, silencing of transposable elements, and genome sta-
bilization. Under physiological conditions, DNA methylation is erased and then 
established genome-wide during gametogenesis and embryogenesis. De novo DNA 
methylation by the enzymatic reaction of the de novo DNA methyltransferases 
(DNMTs), DNMT3A and DNMT3B, occurs during the establishment of DNA 
methylation patterns specific to each germ cell type or somatic cell type after the 
erasure. Once cell type-specific DNA methylation patterns are established dur-
ing embryogenesis, which can extend to early childhood, the maintenance of 
DNA methyltransferase DNMT1 and its cofactor UHRF1 cooperatively maintain 
the pattern throughout the individual’s lifetime. Recently, our group found that 
UHRF1 is also involved in de novo DNA methylation during oogenesis. Moreover, 
our group has identified two genes, CDCA7 and HELLS, to be the causative genes 
of ICF syndrome, characterized by hypomethylation of centromeric and peri-
centromeric repetitive sequences. Because CDCA7/HELLS comprise a chromatin 
remodeling complex, there are evidently certain regions where chromatin remodel-
ing is required to achieve maintenance of DNA methylation. In this chapter, the 
current situation with respect to our understanding of de novo and maintenance 
of DNA methylation mechanisms under physiological conditions in mammals is 
summarized.
Keywords: de novo DNA methylation, maintenance of DNA methylation, 
embryogenesis, gametogenesis, oocyte, PGC, ubiquitylation, UHRF1, DNMT1, 
DNMT3A, DNMT3B, DNMT3L, ICF syndrome, CDCA7, HELLS,  
chromatin remodeling
1. Introduction
Methylation at the C5 positions of cytosine (i.e., 5mC) in the CpG context 
(hereafter called DNA methylation) plays a major role in the transcriptional regula-
tion of gene expression, the silencing of transposable elements (TEs), and genome 
integrity. The enzymatic activities catalyzing DNA methylation can be classified 
into two types. One is de novo DNA methylation, which is an activity by which 
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methyl groups are added to cytosine at unmethylated DNA; de novo DNA methyl-
transferases DNMT3A and DNMT3B, together with their coactivator DNMT3L, 
are known to catalyze this reaction [1]. The other DNA methylation type is mainte-
nance of DNA methylation, an activity by which unmethylated cytosine residues of 
hemi-methylated DNA (cytosine methylation on only one strand of the CG dyad) 
are methylated after DNA replication; DNA methyltransferase 1 (DNMT1) and its 
cofactor, ubiquitin-like, containing PHD and RING finger domains 1 (UHRF1), are 
responsible for this function [2]. In this chapter, the current status of knowledge 
of the two types of DNA methylation, including recent findings from our group, is 
summarized. In addition, possible mechanisms underlying the control of region-
specific methylation by de novo DNMTs as well as possible maintenance of DNA 
methylation mechanisms, with or without chromatin remodeling, are discussed.
2. De novo DNA methylation
2.1 Timing of physiological de novo DNA methylation
De novo DNA methylation is a process by which methyl groups are added to 
unmethylated DNA at specific CpG sites, catalyzed by DNMT3A and DNMT3B 
[1]. In most differentiated cells, de novo DNA methylation is basically undesirable, 
since precise maintenance of the DNA methylation pattern, once established, is 
essential to sustain the appropriate functions of each cell type. Under physiological 
conditions, DNA methylation is widely erased, and then cell-type specific DNA 
methylation patterns are established during gametogenesis and embryogenesis 
[3] (Figure 1). During oogenesis and spermatogenesis, de novo DNA methylation 
occurs to establish oocyte- and sperm-specific DNA methylation patterns, fol-
lowing its elimination in primordial germ cells (PGCs). During post-implantation 
embryogenesis, which can extend to early childhood, de novo DNA methylation 
occurs to establish DNA methylation patterns specific to each cell type after they are 
erased in preimplantation embryos.
Figure 1. 
Known factors involved in dynamic physiological demethylation and de novo DNA methylation during mouse 
gametogenesis and embryogenesis. DNA methylation is widely erased, and then sex-specific or cell type-
specific DNA methylation patterns are established during gametogenesis and embryogenesis. Levels of DNA 
methylation of imprinting control regions (ICRs) and some transposable elements (TEs) are maintained in the 
face of genome-wide demethylation in preimplantation embryos. DOHaD, developmental origins of health 
and disease; SCMC, subcortical maternal complex; E6.5, embryonic day 6.5; E10.5, embryonic day10.5; E12.5, 
embryonic day 12.5.
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The erasure of DNA methylation in PGCs is probably the result of a defect 
in maintenance of DNA methylation, caused by the diminished expression of 
UHRF1 in the cells [4]. After the demethylation, DNMT3A establishes the methyla-
tion pattern in combination with DNMT3L, which itself does not possess enzymatic 
activity but is indispensable for the activity of DNMT3A [5–7] in oocytes arrested at 
an early stage of the first meiotic division or in prospermatogonia arrested at the G1 
phase [8]. Although the major role of UHRF1 is in the maintenance of DNA meth-
ylation (Section 2.2), our group has recently found that UHRF1 is involved in 25% 
of the genome-wide de novo DNA methylation in oocytes [9]. The absence of the 
UHRF1 protein preferentially decreased DNA methylation levels at transcription-
ally inactive regions without histone H3 trimethylation at lysine 36 (H3K36me3) 
mark. Given that only a small percentage decrease in DNA methylation was 
observed in DNMT1 KO oocytes [10] and that UHRF1 has the potential to interact 
with de novo DNMTs [11], UHRF1 may cooperate with DNMT3A for the establish-
ment of methylation patterns. Despite the involvement of UHRF1 in de novo DNA 
methylation in oocytes, our group found that the localization of UHRF1 in oocytes 
is mainly in the cytoplasm [9]. Recently, cytoplasmic Stella (also known as DPPA3 
and PGC7), which is localized in both the cytoplasm and the nucleus, is reported to 
contribute to the cytoplasmic localization of UHRF1 in oocytes to prevent aber-
rantly excessive de novo DNA methylation by the UHRF1 protein complex [12]. 
Nuclear Stella is also reported to inhibit the association of UHRF1 with chromatin, 
resulting in a possible double-layer mechanism to prevent aberrant de novo DNA 
methylation by the complex [13].
During post-implantation embryogenesis and early childhood, not only 
DNMT3A but also DNMT3B proves to be essential for establishing the characteristic 
methylation pattern [14]. These enzymes may work together or independently to 
establish specific DNA methylation patterns in each cell type. However, it still has 
to be determined when the establishment of the methylation pattern is completed, 
although it probably depends on the cell type. The “developmental origins of health 
and disease” (DOHaD) is a concept that has emerged over the past three decades, 
linking the risk of diseases in later childhood and adult life with the environ-
mental conditions of the early life, including nutrient availability to the mothers. 
Accumulating evidence suggests that the environment can change the epigenetic 
state, including DNA methylation of the fetus and infant, with the state being 
maintained throughout the lifetime of the individual [15]. A well-known experi-
ment showed that early experience in childhood permanently alters behavior and 
physiology; interactions between rat mothers and their offspring, including the 
licking and grooming of the pups by their mother in the first week of life, altered 
the DNA methylation status of the glucocorticoid receptor promoter in the hippocam-
pus of the offspring, resulting in differential stress tolerance among the offspring 
[16]. This indicates that the establishment of DNA methylation is not complete by 
the first week after birth, at least in the hippocampal neurons of the rat.
2.2 Specification of de novo DNA methylation sites
The mechanisms underlying the specification of the genomic regions targeted 
by de novo DNMTs have remained largely elusive. In oocytes, a significant positive 
correlation between transcription and highly methylated regions has been reported 
[17]. It is known that transcriptionally active regions are marked with H3K36me3 
and that the histone methyltransferase SET domain containing 2 (SETD2) is 
responsible for the histone methylation in oocytes [18]. Since SETD2 is reported to 
interact with the phosphorylated C-terminal domain of RNA polymerase II (RNA 
pol II) [19], SETD2 appears to methylate histones at regions actively transcribed 
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by the polymerase. On the other hand, the PWWP domain of DNMT3A recognizes 
H3K36me3 [20], and mutations in this domain, which disrupt this recognition, 
cause microcephalic dwarfism with aberrant DNA methylation in humans and 
in a mouse model [21, 22]. Oocyte-specific SETD2 KO also causes aberrant DNA 
methylation [23]. Taken together, it appears that SETD2 methylates H3K36 accom-
panied by transcription by RNA pol II and DNMT3A recognizes the histone mark 
and methylates the DNA, resulting in the establishment of DNA methylation 
patterns specific to oocytes (Figure 2). However, there are exceptions. For example, 
as described above, UHRF1 is involved in 25% of the genome-wide de novo DNA 
methylation, mostly at transcriptionally inactive regions lacking the H3K36me3 
mark [9]. It is still unknown which factors trigger transcription in oocytes, although 
transcription from long terminal repeat (LTR)-retrotransposons, whose methyla-
tion is erased in PGCs, could be one such trigger [24].
During embryogenesis, transcription factors probably define certain transcribed 
regions in each cell type as only four transcriptional factors (OCT3/4, SOX2, 
KLF4, and MYC), together known as OSKM or Yamanaka factors, can drive drastic 
transcriptional change and define epigenetically active regions in differentiated 
cells, resulting in induced pluripotent stem (iPS) cells [25]. DNMTs can access 
regions, where the transcription factors are absent, to passively specify regions for 
DNA methylation (Figure 3). Noncoding RNAs, such as PIWI-interacting RNAs 
(piRNAs) and long noncoding RNAs (lncRNAs), can also contribute to the speci-
fication of regions for DNA methylation (Figure 3). piRNAs are the largest class 
(26–31 nucleotides) of small noncoding RNA expressed in animal cells, which were 
first discovered in Drosophila as RNAs interacting with the PIWI protein; human 
and mouse homologs are HIWI and MIWI, respectively. In most cases, precursor 
piRNAs are derived from piRNA clusters in the genome composed of mutated TEs. 
The precursor piRNAs are processed by several steps and matured by the addition 
of a methyl group at their 3′ ends [26]. Then, the maturated piRNAs interact with 
Argonaute (AGO) family proteins and cleave the TEs, which are undesirably tran-
scribed by the erasure of DNA methylation in PGCs [26]. Although the underlying 
mechanisms are unknown, piRNAs silence these TEs by epigenetic modifications, 
including DNA methylation, especially during spermatogenesis [27]. In addition, 
lncRNAs can specify de novo DNA methylation-acquired regions. X-inactive spe-
cific transcript (XIST) is one of the best-studied lncRNAs. XIST RNA is randomly 
expressed from one of two X-chromosomes in mammalian female cells during 
Figure 2. 
A model for transcription-coupled and transcription-uncoupled de novo DNA methylation in oocytes. 
SETD2 methylates H3K36 accompanied with transcription by RNA polymerase II, and DNMT3A recognizes 
the histone mark and methylates DNA, resulting in the establishment of DNA methylation pattern specific 
to oocytes. Long terminal repeat (LTR)-retrotransposons activated in PGCs may be partially involved in 
triggering the transcription. Although UHRF1 is involved in the de novo DNA methylation of regions without 
the H3K36me3 mark, there could be additional mechanisms for transcription-uncoupled de novo DNA 
methylation.
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embryogenesis and covers the X-chromosome in cis to trigger silencing of most 
genes on it by several layers of epigenetic modifications, including DNA methyla-
tion, to achieve dosage compensation [28, 29].
3. Maintenance of DNA methylation
3.1 Maintenance of DNA methylation by the DNMT1/UHRF1 complex
Once DNA methylation patterns specific to each cell type are established, the 
pattern is maintained by the DNMT1/UHRF1 complex throughout the individual’s 
lifetime [2]. UHRF1 (also known as Np95 or ICBP90) is a multidomain protein, 
which contains a ubiquitin-like (UBL) domain, a tandem Tudor domain (TTD), a 
plant homeodomain (PHD) finger, a SET and RING-associated (SRA) domain, and 
a really interesting new gene (RING) domain. The TTD recognizes di−/tri-methyl-
ated H3K9 (H3K9me2/me3) and also LIG1 (LIG1K126me2/me3) [30, 31], the  
PHD recognizes the unmethylated N-terminus of histone H3 and LIG1 [32], the 
SRA domain recognizes hemi-methylated DNA at the replication fork [33–35], 
and the RING domain mono-ubiquitylates multiple lysines of histone H3 at K14, 
K18, and K23 and those of the PCNA-associated factor 15 (PAF15) at K15 and K24 
[36–39]. The UBL domain facilitates both the RING-mediated ubiquitylation and 
the SRA-mediated recognition of hemi-methylated DNA [40, 41].
Current consensus has it that the process of maintenance of DNA methylation 
operates as follows. After DNA replication, UHRF1 directly recognizes hemi-methyl-
ated DNA and mono-ubiquitylates histone H3K14, K18, and K23, to recruit DNMT1 
to the hemi-methylation sites. Then, DNMT1 recognizes two of the three ubiquity-
lated histone lysine residues through the replication foci targeting sequence (RFTS) 
Figure 3. 
A model for formation of transcriptionally active and silenced regions during embryogenesis. 
Transcription factors (TFs) could define transcriptionally active regions, while small RNAs and lncRNAs 
could define transcriptionally silenced regions in addition to transcription-coupled de novo DNA 
methylation. After transcriptionally active and silenced regions could be actively determined, suppressive 
mark modifiers, such as de novo DNMTs, may add suppressive epigenetic marks to accessible regions, 
which transcriptional machineries do not occupy, resulting in the passive formation of transcriptionally 
silenced regions.
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domain and methylates the nascent strand in hemi-methylated DNA, resulting in the 
maintenance of the methylation patterns (Figure 4). Immediately prior to the meth-
ylation of hemi-methylated DNA by DNMT1, it has been reported that the deubiq-
uitylation of histones by ubiquitin specific peptidase 7 (USP7) is required [42]. DNA 
ligase 1 (LIG1), which is critical for the joining together of Okazaki fragments [43], 
is also involved in this process [31]. Euchromatic histone lysine methyltransferase 2 
(EHMT2, also called G9a) and EHMT1 (also called GLP) methylate K126 of LIG1. 
UHRF1 recognizes the methylated LIG1, and this interaction facilitates the recruit-
ment of UHRF1 to DNA replication sites. Since LIG1 is indispensable for completing 
the lagging strand synthesis, the interaction between UHRF1 and LIG1 may be 
especially important for maintenance of DNA methylation of the strand (Figure 4).
3.2  Maintenance of DNA methylation by the CDCA7/HELLS chromatin 
remodeling complex
The cell division cycle-associated 7 (CDCA7)/helicase lymphoid-specific 
(HELLS) chromatin remodeling complex is also involved in maintenance of DNA 
methylation. Recently, an international group including us identified CDCA7 
Figure 4. 
A model of maintenance of DNA methylation where the CDCA7/HELLS complex is unrequired or required. 
After DNA replication, UHRF1 directly recognizes hemi-methylated DNA, and mono-ubiquitylates multiple 
histone lysines, H3K14, K18, and K23, to recruit DNMT1 to the hemi-methylation sites. Consequently, 
DNMT1 recognizes two of the three ubiquitylated lysine residues through the replication foci targeting sequence 
(RFTS) domain and methylates the nascent strand in hemi-methylated DNA, resulting in the maintenance 
of the methylation pattern. LIG1 methylated by G9a/GLP helps UHRF1 to maintain DNA methylation. In 
addition, the CDCA7/HELLS complex is required for maintaining the DNA methylation of centromeric and 
pericentromeric regions. The complex may also be required for maintaining regions that are heterochromatic, 
late replicating, and histone H1 rich, all these regions being nucleosome dense.
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and HELLS (also known as LSH) to be causative genes of the immunodeficiency, 
centromeric instability, facial anomalies (ICF) syndrome type-3 and type-4 
(hereafter ICF3 and ICF4), respectively [44]. The syndrome is a rare autosomal 
recessive disorder characterized by reduced immunoglobulin levels in the serum 
and recurrent infection [45]. Centromeric instability manifests as stretched het-
erochromatin, chromosome breaks, and multiradial configurations involving the 
centromeric/pericentromeric regions of chromosomes 1, 9, and 16 in activated 
lymphocytes [46], and the cytological defects are accompanied by DNA hypo-
methylation in pericentromeric satellite-2 and -3 repeats of these chromosomes.
Patients with the ICF syndrome are classified into two groups [47]. One group 
includes ICF syndrome type-1 (ICF1), which shows DNA hypomethylation only at the 
pericentromeric repeats. A causative gene for this group is DNMT3B [1, 48, 49]. The 
second group includes ICF syndrome type-2, type-3, and type-4 (ICF2, ICF3, and ICF4, 
respectively), which shows DNA hypomethylation at centromeric α-satellite repeats in 
addition to the pericentromeric repeats. As described above, causative genes for ICF3 
and ICF4 are CDCA7 and HELLS, respectively [44]. The causative gene for ICF2 is zinc 
finger and BTB domain containing 24 (ZBTB24) [50]. As ZBTB24 is a transcriptional acti-
vator of CDCA7 [51, 52], and CDCA7 and HELLS constitute a chromatin remodeling 
complex, in which CDCA7 stimulates the nucleosome remodeling activity of HELLS 
[53], the same pathway seems to be disrupted in ICF2, ICF3, and ICF4.
A recent study revealed that, in addition to centromeric and pericentromeric 
repeats, DNA methylation levels of other heterochromatic late-replicating regions 
are affected in ICF2, ICF3, and ICF4 patients, though not in ICF1 patients [54]. As 
UHRF1 KO and DNMT1 KO cause hypomethylation of the entire genome, including 
centromeric and pericentromeric repeats [2], the DNMT1/UHRF1 complex is surely 
essential for maintaining these regions. However, the CDCA7/HELLS complex 
seems to be required for assisting the DNMT1/UHRF1 complex to methylate hemi-
methylated DNA, possibly by sliding nucleosomes in a region-specific manner 
[53]. Supporting this idea, our group detected an interaction between CDCA7 and 
UHRF1 [55]. Late-replicating regions tend to be heterochromatic regions, where the 
nucleosome density is high. Therefore, the CDCA7/HELLS chromatin remodeling 
complex may be required for such regions (Figure 4).
Using human embryonic kidney 293 cells, our group reported that DNMT3B 
KO caused a slight decrease in DNA methylation of pericentromeric repeats after 
4 months of KO by the CRISPR/Cas9 system, while CDCA7 KO and HELLS KO 
caused drastic decreases in DNA methylation even after only 2 months [55], indicat-
ing that the CDCA7/HELLS chromatin remodeling complex is essential for main-
taining the DNA methylation of the repeats, whereas the requirement of DNMT3B 
for the maintenance is limited in differentiated cells. In the CDCA7 KO and HELLS 
KO cells, DNA methylation levels of centromeric repeats were also decreased, 
but the level of decrease was much less than that of pericentromeric repeats. This 
indicates that the CDCA7/HELLS complex is less essential for maintenance of DNA 
methylation of centromeric repeats. Because the chromatin structure, density of 
nucleosomes, and histone variants are different between centromeric and pericen-
tromeric regions, these differences may determine the levels of requirement for 
the chromatin remodeling complex. In addition, it has been reported that nucleo-
somes and the linker histone H1 are barriers to access of DNMTs to DNA and that 
HELLS and deficient in DNA methylation 1 (DDM1), a plant homolog of HELLS, 
are required for the methylation of DNA wrapped around nucleosomes [56, 57]. 
Consistent with these reports, the most abundant proteins co-immunoprecipitated 
with human CDCA7 were histone H1 and core histones in our group’s report [55]. 
The interaction between the CDCA7/HELLS complex and histone H1 may also be 
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a cue to identify regions where the complex is required for maintenance of DNA 
methylation (Figure 4).
3.3  Maintenance of DNA methylation by the proteins associated with multi-
locus imprint disorder
It is reported that mutations in genes encoding zinc finger protein 57 (ZFP57) 
and components of subcortical maternal complex (SCMC), including NLRP2, 
NLRP5, NLRP7, PADI6, OOEP, and TLE6, cause the multi-locus imprint disorder, 
which exhibits DNA hypomethylation at multiple imprinting control regions 
(ICRs) [58–61]. Since the hypomethylation is observed in both paternally and 
maternally methylated ICRs, these factors are thought to be involved in mainte-
nance of DNA methylation against genome-wide DNA demethylation in preimplan-
tation embryos (Figure 1). Mutations in ZFP57 cause transient neonatal diabetes 
mellitus [61]. As ZFP57 is a nuclear protein, which recognizes the methylated 
TGCCGC hexanucleotide found in almost all ICRs and which acts together with 
ZNF445, KRAB-associated protein-1 (KAP1), DNMTs, SET domain bifurcated 
histone lysine methyltransferase 1 (SETDB1), and heterochromatin protein 1 (HP1) 
[62, 63], ZFP57 is considered to maintain DNA methylation by directly binding to 
ICRs with such proteins. However, the mechanism by which SCMC components, 
which are localized adjacent to the oocyte membrane, can maintain DNA methyla-
tion at ICRs remains elusive [59]. Among the multi-locus imprint disorder cases, 
just one case, who has a heterozygous mutation (V159 M in isoform 1, V172 M in 
isoform 2) in the TTD of UHRF1, has been reported [60].
4. Conclusions
I identified UHRF1 as a novel methyl-CpG binding protein in 2004 by biotin-
avidin pulldown assay using biotin-labeled methylated DNA mixed with nuclear 
extracts and subsequent mass spectrometric analysis [64, 65]. Since then, an under-
standing of the mechanism by which maintenance of DNA methylation is achieved 
has quickly expanded and deepened, progress that I would never have imagined at 
that time. When the involvement of UHRF1 in maintenance of DNA methylation 
was reported [2], the recognition of hemi-methylated DNA by UHRF1 was reported 
[32, 34, 35], and the ubiquitylation of histone H3 by UHRF1 was reported [36], 
each time I felt that the mechanism of maintenance of DNA methylation had been 
resolved. However, the mechanism is more complicated than expected, and more 
factors could still be involved to assist the DNMT1/UHRF1 complex, depending on 
context such as replication timing, replication strand, and higher-order chromatin 
structure. We still cannot take our eyes off advances in this field.
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